Latest News

Researchers at Yale University have developed a way to employ a pair of microscopic technologies to provide a glimpse of the entire brain at work in real time.

Brian Fuehrlein, MD, PhD, Associate Professor of Psychiatry, has been selected to be a member of the American College of Psychiatrists, an honorary association that supports the highest standards in psychiatry.

Greg Rhee, PhD, MSW, Adjunct Assistant Professor of Psychiatry, and Robert Rosenheck, MD, Professor of Psychiatry and of Health Policy, are co-authors of a paper published in Drug and Alcohol Dependence that found the rate of drug overdose deaths in Connecticut has more than doubled since 2012.

Yale researchers sought to understand levels of job burnout among mental health staff. In a study published in the Community Mental Health Journal on Oct. 5, they examined the mental health states of staffers working at the Connecticut Veterans Affairs Errera Community Care Center, or ECCC. The researchers found that among this group, feelings of accomplishment can coexist with negative experiences of emotional exhaustion and depersonalization. Among the authors were Jack Tsai, PhD, Associate Professor of Psychiatry, and Anne Klee, PhD, Assistant Professor of Psychiatry.

The Partnership for Early Education Research (PEER) was pleased to host its fifth annual partnership meeting on Thursday, October 24. The event focused on research that supports Aligning School and Family Assets to Promote Early Learning.

Playwright and activist Eve Ensler gave the keynote address at the inaugural Women's Mental Health Conference at Yale on October 25.

Senior physicians at Yale New Haven Hospital were in the middle of presentations during a recent meeting of the graduate medical education committee when a group of interns, residents and fellows interrupted. At the front of the room, they unfurled a banner painted with the words “Doctors Are Humans Too.”

Frank D. Buono, PhD, Associate Research Scientist in Psychiatry, will lobby members of Congress on behalf of several advocacy groups in Washington, D.C. in February 2020 to increase funding for the rare genetic disease called Neurofibromatosis (NF).

There is a paucity of evidence-based treatments for co-occurring opioid use disorder and chronic pain. These inter-related chronic medical conditions have been central to the unfolding of the opioid crisis. A new study by researchers at Yale, Johns Hopkins, University of Bridgeport, and Western Connecticut State University published in the Journal of Clinical Psychology suggests that psychological variables are important treatment targets for co-occurring opioid use disorder and chronic pain.